MapLight Therapeutics, Inc. MPLT Income Statement
| FY'25 | ||
|---|---|---|
| $138.35M— | ||
| $30.73M— | ||
| $169.08M— | ||
| -$169.08M— | ||
| $7.93M— | ||
| -$161.15M-108% | ||
| —— | ||
| -$168.51M— | ||
| -$169.08M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is MapLight Therapeutics, Inc. profitable?
- MapLight Therapeutics, Inc. is not currently profitable: it reported a net loss of $199.5M over the trailing twelve months.
- What is MapLight Therapeutics, Inc. 's earnings per share?
- MapLight Therapeutics, Inc. 's diluted EPS over the trailing twelve months is $-95.86.
- Where does MapLight Therapeutics, Inc. 's income statement data come from?
- Every line is extracted from MapLight Therapeutics, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.